Dec 06 Panel calls for stronger leadership, clearer mission of FDA foods program By JoNel Aleccia, Associated Press A panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health. Continue reading
Oct 17 You can now buy lower-cost hearing aids over the counter. Here’s how By Phil Galewitz, Kaiser Health News The new options are intended for adults with mild to moderate hearing loss — a market of tens of millions of people, many of whom have until now avoided getting help because aids were so expensive. Continue reading
Oct 06 New survey suggests little progress against stopping U.S. teens from vaping By Mike Stobbe, Matthew Perrone, Associated Press The latest government study on teen vaping suggests there's been little progress in keeping e-cigarettes out of the hands of kids. Continue reading
Sep 30 U.S. outlines plan for long-term baby formula imports By Matthew Perrone, Associated Press The Friday announcement from the Food and Drug Administration aims to diversify the nation's highly concentrated formula industry and prevent future shortages. Continue reading
Sep 26 Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds By Associated Press Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11. Continue reading
Sep 07 FDA panel backs much-debated ALS drug in rare turnaround By Matthew Perrone, Associated Press A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group. Continue reading
Aug 31 Watch 5:57 News Wrap: FDA authorizes omicron boosters, inspectors head to Ukraine nuclear plant In our news wrap Wednesday, the Food and Drug Administration authorized two updated COVID-19 boosters to target the omicron strain of the virus, life expectancy in the U.S. fell to just over 76 years as the pandemic continued to take… Continue watching
Aug 30 FDA chief says long-awaited opioid epidemic review still in the works By Matthew Perrone, Associated Press The head of the Food and Drug Administration says a government review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway. Continue reading
Aug 24 House panel says Trump staffers pressured FDA to authorize unproven COVID-19 treatment By Matthew Perrone, Kevin Freking, Associated Press A special House panel looking into the government's coronavirus response says the Trump White House tried to pressure U.S. health experts into reauthorizing the drug hydroxychloroquine that had been discredited as a COVID-19 treatment. Continue reading
Aug 20 Watch 4:50 How the FDA’s new rule expands access to hearing aids for millions Nearly 48 million Americans have some level of hearing loss, but the high costs of hearing devices is prohibitive for many people. This week, the FDA cleared the way for hearing aids to be sold over the counter — a… Continue watching